CureSearch for Children's Cancer funds and supportstargeted and innovative children's cancer research with measurableresults, and is the authoritative source of information and resourcesfor all those affected by children's cancer.
As part of the CureSearch Investigational Research Initiative, CureSearch for Children's Cancer this year will provide 12 $100,000 grants for scientists focused on innovative research offering the greatest potential to design treatments and improve outcomes for children with difficult-to-treat cancers.
Working with a panel of children's cancer research experts, CureSearch identified 12 areas of study that present the highest risk with the poorest outcomes for children with cancer. "We recognize that for many types of children's cancer, survival rates have not significantly increased in the past two decades," said Stuart Siegel, MD who is Chair of the CureSearch Board of Directors and Director of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles. "By strategically placing funds in the hands of researchers focused on these cancers, we hope to help move the needle so that more children have a chance for a cure."
With the advent of new scientific advances -- genomics, proteomics, targeted therapies, experimental therapeutics, biomarkers, and functional testing -- scientists are now equipped to advance research at a pace faster than ever. Recognizing the tremendous opportunities these new scientific approaches present, CureSearch seeks Young Investigators who are applying these advances to the field of children's cancer research in the following areas:
By focusing on research in these areas whose outcomes have the potential to turn into clinical trials that will one day be available through the Children's Oncology Group or other collaborative clinical trials networks, CureSearch hopes to help speed the transition from scientific advancement to treatment.
CureSearch will fund at least one Young Investigator in each of the above disciplines every year beginning in 2012. Awards of $100,000 over two years will be provided, with the possibility of extension.
Applications for grants in ALL, neuroblastoma, bone, and kidney cancers currently being accepted through June 22 and are available on Proposal Central at https://proposalcentral.altum.com/
For more information about research funded by CureSearch, click here.
Back to Main
Shelby HammondCommunications Manager Email Shelby(240) 235-2205